This section contains press releases and other materials from third parties (including paid content). JOBFlocks has not reviewed this content. Please see disclaimer.
WELL Health Technologies: TD Maintains Buy Rating and C$8.50 Target
WELL Health Technologies Corp. (WELL:CA) — TD Securities maintained its Buy rating with a C$8.50 price target. WELL Health reported record second-quarter revenue, strong growth in Canadian patient services and higher annual guidance, supported by acquisitions and organic expansion. Looking ahead, investors will be watching whether clinic growth improves earnings and free cash flow per share. Acquisition integration, staffing costs and balance-sheet discipline remain important as the healthcare platform expands.
The post WELL Health Technologies: TD Maintains Buy Rating and C$8.50 Target appeared first on Stock Target Advisor.
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
